Recall Atlas
Drugs & medicalClass III

Leading Pharma, LLC recalls ClomiPRAMINE Hydrochloride Capsules, USP 25mg, 100-count bottles, Rx only, LEADING PHARMA, Manufactured by: Leading Pharma, LLC,…

Superpotent Drug: Assay value found to be 110.6% in Chlomipramine Hydrocholoride capsules

Read the official notice →
Date
2022-10-05
Country
United States
Brand
Leading Pharma
Product
ClomiPRAMINE Hydrochloride Capsules, USP 25mg, 100-count bottles, Rx only, LEADING PHARMA, Manufactured by: Leading Pharma, LLC,…
Classification
Class III
Units
Nationwide within the United States
Category
Drugs & medical
Source
FDA · Drug

Copied automatically from the US Food and Drug Administration. Details may be shortened or out of date; the official notice is the authoritative source. Disclaimer

What to do

  1. Check the product name, strength and lot number against the official notice.
  2. Do not stop a prescribed medicine without talking to your doctor or pharmacist first.
  3. Ask the pharmacy or supplier about a replacement or refund.

General guidance from Recall Atlas. The official notice from the US Food and Drug Administration has the exact models, batch codes and remedy, and it takes priority.

More Leading Pharma recalls

  1. 2026-04-29
  2. US
    Drugs & medicalClass II

    Leading Pharma, LLC recalls Furosemide Tablets, USP, 80 mg, 100 Tablets bottles, Rx only, Manufactured by: Leading Pharma, LLC, Fairfield, NJ 07004, NDC 69315-118-01

    CGMP Deviations; presence of N-nitroso-Furosemide (NNF) above the recommended intake limit.

    FDA · DrugLeading Pharma, LLCUS Nationwide.Official notice →
All 2 Leading Pharma recalls →

Other drugs & medical recalls in the United States

  1. 2022-10-05
  2. US
    Drugs & medicalClass II

    bioMerieux, Inc. recalls VIDAS CMV IgM, 30 tests, REF 30205-01, IVD, Rx.

    Invalid calibrations (out of range high) while using the product.

    FDA · DevicebioMerieux, Inc.Distribution was made to CA, FL, GA, IL, IN, LA, MA, MD, ME, MO, NJ, NY, OH,…Official notice →
  3. US
    Drugs & medicalClass III

    ALMIRALL, LLC recalls Xolegel (ketoconazole) gel 2%, 45 gram tubes, Rx only, Manufactured by: DPT Laboratories, San Antonio, TX 78215, NDC 16110-080-45

    Failed Viscosity specification: Slightly higher OOS results obtained for viscosity

    FDA · DrugALMIRALL, LLCNationwide within the United StatesOfficial notice →
  4. US
    Drugs & medicalClass II

    Akorn, Inc. recalls Rifampin Capsules, USP, 150 mg, 30-count bottle, Rx only, Distributed by: Akorn Operating Company, LLC, Gurnee, IL 60031, NDC 61748-015-30

    Failed impurities/degradation specifications: Finished product exceeds the 5 ppm interim limit for 1-Methyl-4-Nitrosopoperazine (MNP).

    FDA · DrugAkorn, Inc.USA Nationwide and Puerto RicoOfficial notice →
  5. US
    Drugs & medicalClass II

    CIPLA recalls Budesonide Inhalation Suspension 0.25mg/2mL, For Inhalation Only, Rx Only, 1 envelope x five 2 mL Single Dose Ampules per pouch, Sterile…

    Lack of Assurance of Sterility

    FDA · DrugCIPLANationwide in the USA and Puerto RicoOfficial notice →
  6. US
    Drugs & medicalClass III

    QuVa Pharma, Inc. recalls oxyTOCIN 30 Units/500 mL (0.06 Units/mL) added to 0.9% Sodium Chloride, Injection for IV Use, High Alert, This is a Compounded Product for…

    Incorrect Product Formulation: Oxytocin 30 units was added to an IV bag of 0.45% Sodium Chloride (500mL) instead of 0.9% Sodium Chloride (500mL).

    FDA · DrugQuVa Pharma, Inc.Nationwide in the USAOfficial notice →
  7. US
    Drugs & medicalClass II

    Novartis Pharmaceuticals Corporation recalls Neoral soft gelatin capsules (cyclosporine capsules, USP) Modified, 25 mg, Rx Only, 30 Soft Gelatin Capsules per carton,…

    CGMP deviations: Out of specification results obtained during routine stability testing for ethanol content.

    FDA · DrugNovartis Pharmaceuticals CorporationNationwide and Puerto RicoOfficial notice →
See all drugs & medical recalls →